Present and future of cell-penetrating peptide mediated delivery systems: "Is the Trojan horse too wild to go only to Troy?"

Journal of Controlled Release

Volumn 109, Issue 1-3, 2005, Pages 77-85

  Vives, Eric ^a  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

Cell delivery; Cell penetrating peptide (CPP); Targeting; Tat

Indexed keywords

AMINO ACIDS; CELLS; MOLECULAR BIOLOGY; PROTEINS; VIRUSES;

CELL DELIVERY; CELL-PENETRATING PEPTIDES (CPP); TARGETING; TAT;

POLYPEPTIDES;

CARRIER PROTEIN; HOMEODOMAIN PROTEIN; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; CELL ADHESION; CELL ENERGY; CELL SPECIFICITY; CELL TYPE; CONFERENCE PAPER; DROSOPHILA; DRUG DELIVERY SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL;

EID: 28444461040     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.09.032     Document Type: Conference Paper

References (71)

1. M. Green, and P.M. Loewenstein Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein Cell 55 1988 1179 1188
2. A.D. Frankel, and C.O. Pabo Cellular uptake of the Tat Protein from Human immunodeficiency virus Cell 55 1988 1189 1193
3. A. Joliot, C. Pernelle, B.H. Deagostini, and A. Prochiantz Antennapedia homeobox peptide regulates neural morphogenesis Proc. Natl. Acad. Sci. U. S. A. 88 1991 1864 1868
4. D. Derossi, A.H. Joliot, G. Chassaing, and A. Prochiantz The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 1994 10444 10450
5. E. Vives, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017
6. M. Pooga, M. Hallbrink, M. Zorko, and U. Langel Cell penetration by transportan Faseb J. 12 1998 67 77
7. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
8. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U. S. A. 97 2000 13003 13008
9. G. Elliott, and P. O'Hare Intercellular trafficking of VP22-GFP fusion proteins Gene Ther. 6 1999 149 151
10. M.C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19 2001 1173 1176
11. A. Nori, K.D. Jensen, M. Tijerina, P. Kopeckova, and J. Kopecek Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells Bioconjug. Chem. 14 2003 44 50
12. V.P. Torchilin, R. Rammohan, V. Weissig, and T.S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. U. S. A. 98 2001 8786 8791
13. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G.G. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. U. S. A. 100 2003 1972 1977
14. Y.L. Tseng, J.J. Liu, and R.L. Hong Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study Mol. Pharmacol. 62 2002 864 872
15. J.P. Gratton, J. Yu, J.W. Griffith, R.W. Babbitt, R.S. Scotland, R. Hickey, F.J. Giordano, and W.C. Sessa Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo Nat. Med. 9 2003 357 363
16. C. Rudolph, C. Plank, J. Lausier, U. Schillinger, R.H. Muller, and J. Rosenecker Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells J. Biol. Chem. 8 2003 8
17. A. Astriab-Fisher, D.S. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates Biochem. Pharmacol. 60 2000 83 90
18. U. Koppelhus, S.K. Awasthi, V. Zachar, H.U. Holst, P. Ebbesen, and P.E. Nielsen Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates Antisense Nucleic Acid Drug Dev. 12 2002 51 63
19. J.C. Mai, H. Shen, S.C. Watkins, T. Cheng, and P.D. Robbins Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate J. Biol. Chem. 277 2002 30208 30218
20. R. Bhorade, R. Weissleder, T. Nakakoshi, A. Moore, and C.H. Tung Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide Bioconjug. Chem. 11 2000 301 305
21. H.M. Moulton, M.C. Hase, K.M. Smith, and P.L. Iversen HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers Antisense Nucleic Acid Drug Dev. 13 2003 31 43
22. G. Dom, C. Shaw-Jackson, C. Matis, O. Bouffioux, J.J. Picard, A. Prochiantz, M.P. Mingeot-Leclercq, R. Brasseur, and R. Rezsohazy Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation Nucleic Acids Res. 31 2003 556 561
23. M.A. Lindsay Peptide-mediated cell delivery: application in protein target validation Curr. Opin. Pharmacol. 2 2002 587 594
24. G.P. Dietz, and M. Bahr Delivery of bioactive molecules into the cell: the Trojan horse approach Mol. Cell. Neurosci. 27 2004 85 131
25. S.D. Kramer, and H. Wunderli-Allenspach No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides Biochim. Biophys. Acta 1609 2003 161 169
26. M. Zorko, and U. Langel Cell-penetrating peptides: mechanism and kinetics of cargo delivery Adv. Drug Deliv. Rev. 57 2005 529 545
27. N. Zarovni, L. Monaco, and A. Corti Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides Hum. Gene Ther. 15 2004 373 382
28. P. Laakkonen, M.E. Akerman, H. Biliran, M. Yang, F. Ferrer, T. Karpanen, R.M. Hoffman, and E. Ruoslahti Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 9381 9386
29. W. Arap, W. Haedicke, M. Bernasconi, R. Kain, D. Rajotte, S. Krajewski, H.M. Ellerby, D.E. Bredesen, R. Pasqualini, and E. Ruoslahti Targeting the prostate for destruction through a vascular address Proc. Natl. Acad. Sci. U. S. A. 99 2002 1527 1531
30. E.B. Dickerson, N. Akhtar, H. Steinberg, Z.Y. Wang, M.J. Lindstrom, M.L. Padilla, R. Auerbach, and S.C. Helfand Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphabeta3 integrin Mol. Cancer Res. 2 2004 663 673
31. W.C. Shen, and H.J. Ryser Conjugation of poly-l-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins Proc. Natl. Acad. Sci. U. S. A. 75 1978 1872 1876
32. W.C. Shen, and H.J. Ryser Poly (l-lysine) and poly (d-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells Mol. Pharmacol. 16 1979 614 622
33. J.P. Leonetti, G. Degols, and B. Lebleu Biological activity of oligonucleotide-poly(l-lysine) conjugates: mechanism of cell uptake Bioconjug. Chem. 1 1990 149 153
34. S. Futaki Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms Int. J. Pharm. 245 2002 1 7
35. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, and J.B. Rothbard Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res. 56 2000 318 325
36. M. Pooga, U. Soomets, M. Hallbrink, A. Valkna, K. Saar, K. Rezaei, U. Kahl, J.X. Hao, X.J. Xu, H.Z. Wiesenfeld, T. Hokfelt, T. Bartfai, and U. Langel Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo Nat. Biotechnol. 16 1998 857 861
37. A. Phelan, G. Elliott, and P. O'Hare Intercellular delivery of functional p53 by the herpesvirus protein VP22 Nat. Biotechnol. 16 1998 440 443
38. M. Peitz, K. Pfannkuche, K. Rajewsky, and F. Edenhofer Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes Proc. Natl. Acad. Sci. U. S. A. 99 2002 4489 4494
39. E. Hariton-Gazal, J. Rosenbluh, A. Graessmann, C. Gilon, and A. Loyter Direct translocation of histone molecules across cell membranes J. Cell Sci. 116 2003 4577 4586
40. M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, and G. Divita A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucleic Acids Res. 25 1997 2730 2736
41. C. Rousselle, P. Clair, J.M. Lefauconnier, M. Kaczorek, J.M. Scherrmann, and J. Temsamani New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol. Pharmacol. 57 2000 679 686
42. D. Derossi, G. Chassaing, and A. Prochiantz Trojan peptides: the penetratin system for intracellular delivery Trends Cell Biol. 8 1998 84 87
43. A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions Pharm. Res. 19 2002 744 754
44. H.M. Moulton, M.H. Nelson, S.A. Hatlevig, M.T. Reddy, and P.L. Iversen Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides Bioconjug. Chem. 15 2004 290 299
45. E.P. Feener, W.C. Shen, and H.J. Ryser Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes J. Biol. Chem. 265 1990 18780 18785
46. J.S. Wadia, R.V. Stan, and S.F. Dowdy Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10 2004 310 315
47. A.M. Vocero-Akbani, N.V. Heyden, N.A. Lissy, L. Ratner, and S.F. Dowdy Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein [see comments] Nat. Med. 5 1999 29 33
48. W.J. Bruyninckx, K.M. Comerford, D.W. Lawrence, and S.P. Colgan Phosphoinositide 3-kinase modulation of beta(3)-integrin represents an endogenous "braking" mechanism during neutrophil transmatrix migration Blood 97 2001 3251 3258
49. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent J. Biol. Chem. 271 1996 18188 18193
50. D. Terrone, S.L. Sang, L. Roudaia, and J.R. Silvius Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential Biochemistry 42 2003 13787 13799
51. L.R. Wright, J.B. Rothbard, and P.A. Wender Guanidinium rich Peptide transporters and drug delivery Curr. Protein Pept. Sci. 4 2003 105 124
52. M. Lewin, N. Carlesso, C.H. Tung, X.W. Tang, D. Cory, D.T. Scadden, and R. Weissleder Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat. Biotechnol. 18 2000 410 414
53. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
54. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 664 668
55. M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans J. Biol. Chem. 276 2001 3254 3261
56. S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener, and K. Ballmer-Hofer Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans J. Biol. Chem. 278 2003 35109 35114
57. J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, and L.V. Chernomordik Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 280 2005 15300 15306
58. S. Violini, V. Sharma, J.L. Prior, M. Dyszlewski, and D. Piwnica-Worms Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate Biochemistry 41 2002 12652 12661
59. M. Hallbrink, J. Oehlke, G. Papsdorf, and M. Bienert Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration Biochim. Biophys. Acta 1667 2004 222 228
60. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590
61. I. Nakase, M. Niwa, T. Takeuchi, K. Sonomura, N. Kawabata, Y. Koike, M. Takehashi, S. Tanaka, K. Ueda, J.C. Simpson, A.T. Jones, Y. Sugiura, and S. Futaki Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement Molec. Ther. 10 2004 1011 1022
62. J.B. Rothbard, T.C. Jessop, R.S. Lewis, B.A. Murray, and P.A. Wender Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells J. Am. Chem. Soc. 126 2004 9506 9507
63. P.E. Thoren, D. Persson, E.K. Esbjorner, M. Goksor, P. Lincoln, and B. Norden Membrane binding and translocation of cell-penetrating peptides Biochemistry 43 2004 3471 3489
64. I.M. Kaplan, J.S. Wadia, and S.F. Dowdy Cationic TAT peptide transduction domain enters cells by macropinocytosis J. Control. Release 102 2005 247 253
65. M. Lundberg, and M. Johansson Positively charged DNA-binding proteins cause apparent cell membrane translocation Biochem. Biophys. Res. Commun. 291 2002 367 371
66. M. Lundberg, S. Wikstrom, and M. Johansson Cell surface adherence and endocytosis of protein transduction domains Molec. Ther. 8 2003 143 150
67. A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, and M. Giacca Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 tat fusion proteins J. Biol. Chem. 278 2003 34141 34149
68. J.B. Rothbard, S. Garlington, Q. Lin, T. Kirschberg, E. Kreider, P.L. McGrane, P.A. Wender, and P.A. Khavari Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation Nat. Med. 6 2000 1253 1257
69. D.C. Anderson, E. Nichols, R. Manger, D. Woodle, M. Barry, and A.R. Fritzberg Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide Biochem. Biophys. Res. Commun. 194 1993 876 884
70. U. Niesner, C. Halin, L. Lozzi, M. Gunthert, P. Neri, H. Wunderli-Allenspach, L. Zardi, and D. Neri Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides vol. 13 2002 729 736
71. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U. S. A. 101 2004 17867 17872